Hodgkin Lymphoma (HL): Microenvironmental Biology Behind a Therapeutic Success Story - Oncodaily
Hodgkin Lymphoma (HL): Microenvironmental Biology Behind a Therapeutic Success Story Oncodaily
Hodgkin Lymphoma News
Woman, 26, who diagnosed herself with cancer has stern message for the doctors that missed key symptom - UNILAD
Woman, 26, who diagnosed herself with cancer has stern message for the doctors that missed key symptom UNILAD
A Cardio-Obstetric Breakthrough Beyond Routine Pregnancy Care: Unmasking Hodgkin’s Lymphoma - JACC Journals
A Cardio-Obstetric Breakthrough Beyond Routine Pregnancy Care: Unmasking Hodgkin’s Lymphoma JACC Journals
FDA Approves Nivolumab (Opdivo) Combination for Classical Hodgkin Lymphoma - Oncology News Central
FDA Approves Nivolumab (Opdivo) Combination for Classical Hodgkin Lymphoma Oncology News Central
Non-Hodgkin lymphoma survivor thankful for clinical trial - UT MD Anderson
Non-Hodgkin lymphoma survivor thankful for clinical trial UT MD Anderson
Genome-scale spatial mapping of the Hodgkin lymphoma microenvironment identifies tumor cell survival factors - Nature
Genome-scale spatial mapping of the Hodgkin lymphoma microenvironment identifies tumor cell survival factors Nature
Progress in the Treatment of Advanced-Stage Classical Hodgkin Lymphoma in the PET-Adapted Era - CancerNetwork
Progress in the Treatment of Advanced-Stage Classical Hodgkin Lymphoma in the PET-Adapted Era CancerNetwork
Low-Dose Nivolumab Offers Novel Strategy for Hodgkin Lymphoma Treatment - Targeted Oncology
Low-Dose Nivolumab Offers Novel Strategy for Hodgkin Lymphoma Treatment Targeted Oncology
Nivolumab Plus AVD Reduces Disease Progression Risk in Adolescents With Advanced Classical Hodgkin Lymphoma - The ASCO Post
Nivolumab Plus AVD Reduces Disease Progression Risk in Adolescents With Advanced Classical Hodgkin Lymphoma The ASCO Post
Learn About How Survival Rates Are Improving With Hodgkin Disease - Verywell Health
Learn About How Survival Rates Are Improving With Hodgkin Disease Verywell Health
Sintilimab combined with AVD for the treatment of composite Hodgkin lymphoma and follicular lymphoma: a case report and literature review - Frontiers
Sintilimab combined with AVD for the treatment of composite Hodgkin lymphoma and follicular lymphoma: a case report and literature review Frontiers
US FDA approves Bristol Myers Squibb's cancer drug for Hodgkin's lymphoma - Reuters
US FDA approves Bristol Myers Squibb's cancer drug for Hodgkin's lymphoma Reuters
Report: Counties that spray the most glyphosate have higher non-Hodgkin lymphoma rates - Iowa Capital Dispatch
Report: Counties that spray the most glyphosate have higher non-Hodgkin lymphoma rates Iowa Capital Dispatch
Andrew M. Evens: The Early-Stage Hodgkin International Prognostic Index Prediction Model - Oncodaily
Andrew M. Evens: The Early-Stage Hodgkin International Prognostic Index Prediction Model Oncodaily
New treatment combination offers excellent results for early-stage Hodgkin lymphoma with less chemotherapy - UT MD Anderson
New treatment combination offers excellent results for early-stage Hodgkin lymphoma with less chemotherapy UT MD Anderson
Distinct cell state ecosystems for nodular lymphocyte-predominant Hodgkin lymphoma - Nature
Distinct cell state ecosystems for nodular lymphocyte-predominant Hodgkin lymphoma Nature
Durable 3-Year Superiority of N-AVD in Advanced Hodgkin Lymphoma - Targeted Oncology
Durable 3-Year Superiority of N-AVD in Advanced Hodgkin Lymphoma Targeted Oncology
Stage IV non-Hodgkin lymphoma survivor: Why I’m excited about UT MD Anderson coming to Austin - UT MD Anderson
Stage IV non-Hodgkin lymphoma survivor: Why I’m excited about UT MD Anderson coming to Austin UT MD Anderson
Advanced stage classical Hodgkin lymphoma patients with a positive interim-PET (PET-2) Deauville score 5 after 2 ABVD cycles: a pooled analysis of three multicenter trials - Nature
Advanced stage classical Hodgkin lymphoma patients with a positive interim-PET (PET-2) Deauville score 5 after 2 ABVD cycles: a pooled analysis of three multicenter trials Nature
Impact of early failure of induction on transplant outcomes in Hodgkin lymphoma | Bone Marrow Transplantation - Nature
Impact of early failure of induction on transplant outcomes in Hodgkin lymphoma | Bone Marrow Transplantation Nature
‘The Sister Act’: How family and faith helped a young woman beat Hodgkin’s lymphoma - University of California - Davis Health
‘The Sister Act’: How family and faith helped a young woman beat Hodgkin’s lymphoma University of California - Davis Health
A Rare Case of Non-Hodgkin Lymphoma of the Tracheobronchial Tree - Cureus
A Rare Case of Non-Hodgkin Lymphoma of the Tracheobronchial Tree Cureus
Young mother’s Hodgkin lymphoma diagnosis felt ‘devastating’ - Fred Hutchinson Cancer Center
Young mother’s Hodgkin lymphoma diagnosis felt ‘devastating’ Fred Hutchinson Cancer Center
T-Cell Therapy EB103 Demonstrates Safety in B-Cell Non-Hodgkin Lymphoma - Targeted Oncology
T-Cell Therapy EB103 Demonstrates Safety in B-Cell Non-Hodgkin Lymphoma Targeted Oncology
Antibody-Based Therapies for the Treatment of Hodgkin Lymphoma in Older Patients - ASCO Publications
Antibody-Based Therapies for the Treatment of Hodgkin Lymphoma in Older Patients ASCO Publications
First-Line Options in Advanced-Stage Classical Hodgkin Lymphoma: Weighing Efficacy, Toxicity, and Quality of Life in Decision-Making - ASCO Daily News
First-Line Options in Advanced-Stage Classical Hodgkin Lymphoma: Weighing Efficacy, Toxicity, and Quality of Life in Decision-Making ASCO Daily News
Classic Hodgkin’s Lymphoma With Epstein–Barr Viremia and Lymphadenopathy - Wiley Online Library
Classic Hodgkin’s Lymphoma With Epstein–Barr Viremia and Lymphadenopathy Wiley Online Library
Miami F Marcus Allen has non-Hodgkin lymphoma, out for season - ESPN
Miami F Marcus Allen has non-Hodgkin lymphoma, out for season ESPN
An Individualized Prediction Model for Early-Stage Classic Hodgkin’s Lymphoma - NEJM Evidence
An Individualized Prediction Model for Early-Stage Classic Hodgkin’s Lymphoma NEJM Evidence
Breast Mass as an Atypical Presentation of Non-Hodgkin Lymphoma - Cureus
Breast Mass as an Atypical Presentation of Non-Hodgkin Lymphoma Cureus
New Phase 3 Clinical Trial Opens for Pediatric, Adult Hodgkin Lymphoma Patients - Roswell Park Comprehensive Cancer Center
New Phase 3 Clinical Trial Opens for Pediatric, Adult Hodgkin Lymphoma Patients Roswell Park Comprehensive Cancer Center
Richter transformation to classical Hodgkin lymphoma following recurrent disseminated histoplasmosis in chronic lymphocytic leukemia: a Case Report - Frontiers
Richter transformation to classical Hodgkin lymphoma following recurrent disseminated histoplasmosis in chronic lymphocytic leukemia: a Case Report Frontiers
Transformation of Classical Hodgkin Lymphoma Into Non-Hodgkin Lymphoma: Three Case Reports From the West Bank - Wiley Online Library
Transformation of Classical Hodgkin Lymphoma Into Non-Hodgkin Lymphoma: Three Case Reports From the West Bank Wiley Online Library
An Individualized Prediction Model for Early-Stage Classic Hodgkin’s Lymphoma - NEJM Evidence
An Individualized Prediction Model for Early-Stage Classic Hodgkin’s Lymphoma NEJM Evidence
Population based analysis of twenty year incidence trends of pediatric Hodgkin lymphoma in the United States - Nature
Population based analysis of twenty year incidence trends of pediatric Hodgkin lymphoma in the United States Nature
‘Elevated’ Hodgkin’s lymphoma numbers among teens at Medina High School - Cleveland 19 News
‘Elevated’ Hodgkin’s lymphoma numbers among teens at Medina High School Cleveland 19 News
ASH 2025 | Congress coverage: Hodgkin lymphoma and T-cell lymphoma - Lymphoma Hub
ASH 2025 | Congress coverage: Hodgkin lymphoma and T-cell lymphoma Lymphoma Hub
Procalcitonin as a Potential Prognostic Marker in Advanced Hodgkin Lymphoma: A Case-Based Perspective - Cureus
Procalcitonin as a Potential Prognostic Marker in Advanced Hodgkin Lymphoma: A Case-Based Perspective Cureus
Clinical features and outcomes of newly diagnosed classical Hodgkin lymphoma patients in Saudi Arabia: a multicenter cohort study | Scientific Reports - Nature
Clinical features and outcomes of newly diagnosed classical Hodgkin lymphoma patients in Saudi Arabia: a multicenter cohort study | Scientific Reports Nature
Woman able to understand cancer diagnosis thanks to ‘Grey’s Anatomy’ - The Delta News
Woman able to understand cancer diagnosis thanks to ‘Grey’s Anatomy’ The Delta News